Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Hart XM"'
Autor:
Hart XM; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Gründer G; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; German Center for Mental Health (DZPG), Partner Site Mannheim, Heidelberg, Germany., Ansermot N; Department of Psychiatry, Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Lausanne University Hospital, Prilly, Switzerland., Conca A; Dipartimento di Psichiatria, Comprensorio Sanitario di Bolzano, Bolzano, Italy., Corruble E; Service Hospitalo-Universitaire de Psychiatrie, Hôpital de Bicêtre, Université Paris-Saclay, AP-HP, Le Kremlin-Bicêtre, France.; Equipe MOODS, Inserm U1018, CESP (Centre de Recherche en Epidémiologie et Sante des Populations), Le Kremlin-Bicêtre, France., Crettol S; Department of Psychiatry, Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Lausanne University Hospital, Prilly, Switzerland., Cumming P; Department of Nuclear Medicine, Bern University Hospital, Bern, Switzerland.; School of Psychology and Counseling, Queensland University of Technology, Brisbane, Australia., Frajerman A; Service Hospitalo-Universitaire de Psychiatrie, Hôpital de Bicêtre, Université Paris-Saclay, AP-HP, Le Kremlin-Bicêtre, France.; Equipe MOODS, Inserm U1018, CESP (Centre de Recherche en Epidémiologie et Sante des Populations), Le Kremlin-Bicêtre, France., Hefner G; Forensic Psychiatry, Vitos Clinic for Forensic Psychiatry, Eltville, Germany., Howes O; Department of Psychosis Studies, IoPPN, King's College London, London, UK.; Faculty of Medicine, Institute of Clinical Sciences (ICS), Imperial College London, London, UK., Jukic MM; Department of Physiology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.; Pharmacogenetics Section, Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden., Kim E; Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea., Kim S; Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea., Maniscalco I; Dipartimento di Psichiatria, Comprensorio Sanitario di Bolzano, Bolzano, Italy., Moriguchi S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Müller DJ; Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Würzburg, Germany.; Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada., Nakajima S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Osugo M; Department of Psychosis Studies, IoPPN, King's College London, London, UK.; Faculty of Medicine, Institute of Clinical Sciences (ICS), Imperial College London, London, UK., Paulzen M; Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, Aachen, Germany.; JARA - Translational Brain Medicine, Alexianer Center for Mental Health, Aachen, Germany., Ruhe HG; Department of Psychiatry, Radboudumc, Nijmegen, Netherlands.; Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, Netherlands., Scherf-Clavel M; Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Würzburg, Germany., Schoretsanitis G; Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland., Serretti A; Department of Medicine and Surgery, Kore University of Enna, Enna, Italy., Spina E; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy., Spigset O; Department of Clinical Pharmacology, St. Olav University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Steimer W; Institute of Clinical Chemistry and Pathobiochemistry, Technical University Munich, Munich, Germany., Süzen SH; Department of Pharmaceutic Toxicology, Faculty of Pharmacy, Ankara University, Ankara, Turkey., Uchida H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Unterecker S; Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Würzburg, Germany., Vandenberghe F; Department of Psychiatry, Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Lausanne University Hospital, Prilly, Switzerland., Verstuyft C; Equipe MOODS, Inserm U1018, CESP (Centre de Recherche en Epidémiologie et Sante des Populations), Le Kremlin-Bicêtre, France.; Department of Molecular Genetics, Pharmacogenetics and Hormonology, Bicêtre University Hospital Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Paris, France., Zernig G; Department of Pharmacology, Medical University Innsbruck, Hall in Tirol, Austria.; Private Practice for Psychotherapy and Court-Certified Witness, Hall in Tirol, Austria., Hiemke C; Department of Psychiatry and Psychotherapy and Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of Mainz, Mainz, Germany., Eap CB; Department of Psychiatry, Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Lausanne University Hospital, Prilly, Switzerland.; School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland.; Center for Research and Innovation in Clinical Pharmaceutical Sciences, University of Lausanne, Lausanne, Switzerland.; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Lausanne, Switzerland.
Publikováno v:
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry [World J Biol Psychiatry] 2024 Nov; Vol. 25 (9), pp. 451-536. Date of Electronic Publication: 2024 Sep 01.
Autor:
Hart XM; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan; and., Spangemacher M; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Department of Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Defert J; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Uchida H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan; and., Gründer G; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Publikováno v:
Therapeutic drug monitoring [Ther Drug Monit] 2024 Apr 01; Vol. 46 (2), pp. 155-169. Date of Electronic Publication: 2024 Jan 24.
Autor:
Scherf-Clavel M; Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) Work Group on 'Therapeutic Drug Monitoring' (Chair: Prof. Dr Med. Dipl.-Psych. Stefan Unterecker, Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Germany)., Baumann P; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) Work Group on 'Therapeutic Drug Monitoring' (Chair: Prof. Dr Med. Dipl.-Psych. Stefan Unterecker, Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Germany).; German Society for Clinical Chemistry and Laboratory Medicine e. V. (DGKL), Section Therapeutic Drug Monitoring and Clinical Toxicology, Berlin/Bonn, Germany., Hart XM; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) Work Group on 'Therapeutic Drug Monitoring' (Chair: Prof. Dr Med. Dipl.-Psych. Stefan Unterecker, Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Germany).; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Schneider H; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) Work Group on 'Therapeutic Drug Monitoring' (Chair: Prof. Dr Med. Dipl.-Psych. Stefan Unterecker, Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Germany).; Institute of Clinical Chemistry and Pathobiochemistry, Technical University Munich, Munich, Germany.; German Society for Clinical Chemistry and Laboratory Medicine e. V. (DGKL), Section Therapeutic Drug Monitoring and Clinical Toxicology, Berlin/Bonn.; INSTAND e.V. Society for Promoting Quality Assurance in Medical Laboratories, Duesseldorf, Germany.; German Society for Clinical Chemistry and Laboratory Medicine e. V. (DGKL), Section Therapeutic Drug Monitoring and Clinical Toxicology, Berlin/Bonn, Germany., Schoretsanitis G; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) Work Group on 'Therapeutic Drug Monitoring' (Chair: Prof. Dr Med. Dipl.-Psych. Stefan Unterecker, Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Germany).; Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York.; Department of Psychiatry, Zucker School of Medicine at Northwell/Hofstra, Hempstead, New York.; Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland., Steimer W; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) Work Group on 'Therapeutic Drug Monitoring' (Chair: Prof. Dr Med. Dipl.-Psych. Stefan Unterecker, Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Germany).; Institute of Clinical Chemistry and Pathobiochemistry, Technical University Munich, Munich, Germany.; German Society for Clinical Chemistry and Laboratory Medicine e. V. (DGKL), Section Therapeutic Drug Monitoring and Clinical Toxicology, Berlin/Bonn., Zernig G; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) Work Group on 'Therapeutic Drug Monitoring' (Chair: Prof. Dr Med. Dipl.-Psych. Stefan Unterecker, Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Germany).; Department of Pharmacology, Medical University of Innsbruck, Innsbruck, Austria.; Private Practice for Psychotherapy and Court-certified Expert Witness, Hall in Tirol, Austria; and., Zurek G; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) Work Group on 'Therapeutic Drug Monitoring' (Chair: Prof. Dr Med. Dipl.-Psych. Stefan Unterecker, Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Germany).; Medical Laboratory Bremen, Bremen, Germany.
Publikováno v:
Therapeutic drug monitoring [Ther Drug Monit] 2024 Apr 01; Vol. 46 (2), pp. 143-154. Date of Electronic Publication: 2023 Mar 16.
Autor:
Hart XM; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Mitsukura Y; Department of System Design Engineering, Faculty of Science and Technology, Keio University Japan., Bies RR; Department of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA., Uchida H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Publikováno v:
Pharmacopsychiatry [Pharmacopsychiatry] 2024 Mar; Vol. 57 (2), pp. 53-60. Date of Electronic Publication: 2024 Feb 22.
Autor:
Lense XM; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Heidelberg 68159 University J5, Mannheim, Germany. Xenija.Lense@umm.de., Hiemke C; Clinic of Psychiatry and Psychotherapy, University of Mainz, Mainz, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany., Funk CSM; Institute of Clinical Pharmacology and Toxicology, Charité University, Berlin, Germany., Havemann-Reinecke U; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany.; Clinic of Psychiatry and Psychotherapy, University of Göttingen, Göttingen, Germany., Hefner G; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany.; Vitos Clinic of Forensic Psychiatry, Eltville, Germany., Menke A; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany.; Psychosomatic Clinic Medical Park Chiemseeblick, Bernau a. Chiemsee, Germany.; Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany., Mössner R; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany.; Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen, Germany., Riemer TG; Institute of Clinical Pharmacology and Toxicology, Charité University, Berlin, Germany., Scherf-Clavel M; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany.; Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Würzburg, Germany., Schoretsanitis G; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany.; Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Zürich, Zürich, Switzerland., Gründer G; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Heidelberg 68159 University J5, Mannheim, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany., Hart XM; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Heidelberg 68159 University J5, Mannheim, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Working Group 'Therapeutic Drug Monitoring', Munich, Germany.
Publikováno v:
Psychopharmacology [Psychopharmacology (Berl)] 2024 Feb; Vol. 241 (2), pp. 275-289. Date of Electronic Publication: 2023 Oct 19.
Autor:
Hart XM; Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Spangemacher M; Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Central Institute of Mental Health, Department of Psychiatry, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; and., Uchida H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Gründer G; Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Publikováno v:
Therapeutic drug monitoring [Ther Drug Monit] 2024 Feb 01; Vol. 46 (1), pp. 16-32. Date of Electronic Publication: 2023 Nov 27.
Publikováno v:
Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2024 Jan-Feb 01; Vol. 44 (1), pp. 60-63.
Autor:
Wesner K; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Hiemke C; Department of Psychiatry and Psychotherapy, Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of Mainz, Mainz, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Bergemann N; Department of General Psychiatry, University of Heidelberg, Heidelberg, Germany.; Department of Biological and Clinical Psychology, University of Trier, Trier, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Egberts KM; ); Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg, Würzburg, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Fekete S; ); Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg, Würzburg, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Gerlach M; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Havemann-Reinecke U; Department of Psychiatry and Psychosomatics, University of Göttingen, Göttingen, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Lense XM; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Riemer TG; Charité-Medical University of Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany., Schoretsanitis G; Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland.; Behavioral Health Pavilion, Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, and Department of Psychiatry, Zucker School of Medicine at Northwell/Hofstra, Hempstead, New York.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Uhr M; Clinical Laboratory, Max Planck Institute of Psychiatry, Munich, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Zernig G; Department of Pharmacology, Medical University of Innsbruck, Innsbruck, Austria.; Private Practice for Psychotherapy and Court-Certified Witness, Hall in Tirol, Austria.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Gründer G; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'., Hart XM; Department of Molecular Neuroimaging, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force 'Therapeutic Drug Monitoring'.; Corresponding Author: Xenia M. Hart, Central Institute of Mental Health Mannheim; J5, 68159 Mannheim (xenia.hart@zi-mannheim.de).
Publikováno v:
The Journal of clinical psychiatry [J Clin Psychiatry] 2023 Jul 19; Vol. 84 (5). Date of Electronic Publication: 2023 Jul 19.
Autor:
Hart XM; Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Amann F; Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Brand J; Laboratory Limbach Analytics GmbH, Heidelberg, Germany., Eichentopf L; Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Gründer G; Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Publikováno v:
Pharmacopsychiatry [Pharmacopsychiatry] 2023 Mar; Vol. 56 (2), pp. 73-80. Date of Electronic Publication: 2023 Mar 21.
Autor:
Hart XM; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, J5, 68159, Mannheim, Germany. xenia.hart@zi-mannheim.de., Heesen S; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, J5, 68159, Mannheim, Germany., Schmitz CN; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, J5, 68159, Mannheim, Germany., Dörfler S; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, University of Göttingen, Göttingen, Germany., Wedekind D; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, University of Göttingen, Göttingen, Germany., Gründer G; Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, J5, 68159, Mannheim, Germany., Hiemke C; Institute of Clinical Chemistry and Laboratory Medicine, Department of Psychiatry and Psychotherapy, University Medical Center of Mainz, Mainz, Germany., Havemann-Reinecke U; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, University of Göttingen, Göttingen, Germany.
Publikováno v:
European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2023 Feb; Vol. 273 (1), pp. 75-83. Date of Electronic Publication: 2022 Oct 07.